Literature DB >> 20492846

The neurobiology of the switch process in bipolar disorder: a review.

Giacomo Salvadore1, Jorge A Quiroz, Rodrigo Machado-Vieira, Ioline D Henter, Husseini K Manji, Carlos A Zarate.   

Abstract

OBJECTIVE: The singular phenomenon of switching from depression to its opposite state of mania or hypomania, and vice versa, distinguishes bipolar disorder from all other psychiatric disorders. Despite the fact that it is a core aspect of the clinical presentation of bipolar disorder, the neurobiology of the switch process is still poorly understood. In this review, we summarize the clinical evidence regarding somatic interventions associated with switching, with a particular focus on the biologic underpinnings presumably involved in the switch process. DATA SOURCES: Literature for this review was obtained through a search of the MEDLINE database (1966-2008) using the following keywords and phrases: switch, bipolar disorder, bipolar depression, antidepressant, SSRIs, tricyclic antidepressants, norepinephrine, serotonin, treatment emergent affective switch, mania, hypomania, HPA-axis, glucocorticoids, amphetamine, dopamine, and sleep deprivation. STUDY SELECTION: All English-language, peer-reviewed, published literature, including randomized controlled studies, naturalistic and open-label studies, and case reports, were eligible for inclusion. DATA SYNTHESIS: Converging evidence suggests that certain pharmacologic and nonpharmacologic interventions with very different mechanisms of action, such as sleep deprivation, exogenous corticosteroids, and dopaminergic agonists, can trigger mood episode switches in patients with bipolar disorder. The switch-inducing potential of antidepressants is unclear, although tricyclic antidepressants, which confer higher risk of switching than other classes of antidepressants, are a possible exception. Several neurobiological factors appear to be associated with both spontaneous and treatment-emergent mood episode switches; these include abnormalities in catecholamine levels, up-regulation of neurotrophic and neuroplastic factors, hypothalamic-pituitary-adrenal axis hyperactivity, and circadian rhythms.
CONCLUSIONS: There is a clear need to improve our understanding of the neurobiology of the switch process; research in this field would benefit from the systematic and integrated assessment of variables associated with switching. © Copyright 2010 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20492846      PMCID: PMC3000635          DOI: 10.4088/JCP.09r05259gre

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  155 in total

Review 1.  Glycogen synthase kinase-3: a target for novel bipolar disorder treatments.

Authors:  Todd D Gould; Carlos A Zarate; Husseini K Manji
Journal:  J Clin Psychiatry       Date:  2004-01       Impact factor: 4.384

2.  Relationship between mood changes and adrenal cortical activity in a patient with 48-hour unipolar-depressive cycles.

Authors:  P Doerr; D von Zerssen; M Fischler; H Schulz
Journal:  J Affect Disord       Date:  1979-06       Impact factor: 4.839

3.  Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients.

Authors:  D L Murphy; H K Brodie; F K Goodwin; W E Bunney
Journal:  Nature       Date:  1971-01-08       Impact factor: 49.962

4.  Mood changes during prednisone bursts in outpatients with asthma.

Authors:  E Sherwood Brown; Trisha Suppes; David A Khan; Thomas J Carmody
Journal:  J Clin Psychopharmacol       Date:  2002-02       Impact factor: 3.153

5.  Sleep deprivation increases dopamine D1 receptor antagonist [3H]SCH 23390 binding and dopamine-stimulated adenylate cyclase in the rat limbic system.

Authors:  M G Demontis; P Fadda; P Devoto; M C Martellotta; W Fratta
Journal:  Neurosci Lett       Date:  1990-09-04       Impact factor: 3.046

6.  Antidepressant-associated switches from depression to mania in severe bipolar disorder.

Authors:  Gabrielle A Carlson; Stephen J Finch; Laura J Fochtmann; Qing Ye; Qing Wang; Bushra Naz; Evelyn J Bromet
Journal:  Bipolar Disord       Date:  2007-12       Impact factor: 6.744

7.  Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism.

Authors:  A Rousseva; C Henry; D van den Bulke; G Fournier; J-L Laplanche; M Leboyer; F Bellivier; J-M Aubry; P Baud; M Boucherie; C Buresi; F Ferrero; A Malafosse
Journal:  Pharmacogenomics J       Date:  2003       Impact factor: 3.550

8.  Prednisone effects on neurochemistry and behavior. Preliminary findings.

Authors:  O M Wolkowitz; D Rubinow; A R Doran; A Breier; W H Berrettini; M A Kling; D Pickar
Journal:  Arch Gen Psychiatry       Date:  1990-10

9.  Falret's discovery: the origin of the concept of bipolar affective illness. Translated by M. J. Sedler and Eric C. Dessain.

Authors:  M J Sedler
Journal:  Am J Psychiatry       Date:  1983-09       Impact factor: 18.112

10.  Mania-like behavior induced by disruption of CLOCK.

Authors:  Kole Roybal; David Theobold; Ami Graham; Jennifer A DiNieri; Scott J Russo; Vaishnav Krishnan; Sumana Chakravarty; Joseph Peevey; Nathan Oehrlein; Shari Birnbaum; Martha H Vitaterna; Paul Orsulak; Joseph S Takahashi; Eric J Nestler; William A Carlezon; Colleen A McClung
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-22       Impact factor: 11.205

View more
  41 in total

Review 1.  Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.

Authors:  Jordy van Enkhuizen; Mark A Geyer; Arpi Minassian; William Perry; Brook L Henry; Jared W Young
Journal:  Neurosci Biobehav Rev       Date:  2015-08-19       Impact factor: 8.989

2.  Euthymia, depression, and mania: what do we know about the switch?

Authors:  Hilary P Blumberg
Journal:  Biol Psychiatry       Date:  2012-04-01       Impact factor: 13.382

Review 3.  Investigating the mechanism(s) underlying switching between states in bipolar disorder.

Authors:  Jared W Young; Davide Dulcis
Journal:  Eur J Pharmacol       Date:  2015-03-23       Impact factor: 4.432

4.  Mania Induced by Garcinia cambogia: A Case Series.

Authors:  Brian P Hendrickson; Noreen Shaikh; Mallay Occhiogrosso; Julie B Penzner
Journal:  Prim Care Companion CNS Disord       Date:  2016-04-28

5.  Sleep deprivation impairs performance in the 5-choice continuous performance test: similarities between humans and mice.

Authors:  Jordy van Enkhuizen; Dean Acheson; Victoria Risbrough; Sean Drummond; Mark A Geyer; Jared W Young
Journal:  Behav Brain Res       Date:  2013-12-12       Impact factor: 3.332

6.  Further evidence for ClockΔ19 mice as a model for bipolar disorder mania using cross-species tests of exploration and sensorimotor gating.

Authors:  Jordy van Enkhuizen; Arpi Minassian; Jared W Young
Journal:  Behav Brain Res       Date:  2013-04-23       Impact factor: 3.332

7.  Oxidation and nitration in dopaminergic areas of the prefrontal cortex from patients with bipolar disorder and schizophrenia.

Authors:  Helena Kyunghee Kim; Ana Cristina Andreazza; Pok Yik Yeung; Cameron Isaacs-Trepanier; L Trevor Young
Journal:  J Psychiatry Neurosci       Date:  2014-07       Impact factor: 6.186

Review 8.  Rethinking the spectrum of mood disorders: implications for diagnosis and management - Proceedings of a symposium presented at the 30th Annual European College of Neuropsychopharmacology Congress, 4 September 2017, Paris, France.

Authors:  Roger S McIntyre; Allan H Young; Peter M Haddad
Journal:  Ther Adv Psychopharmacol       Date:  2018-03-25

9.  Antimanic Efficacy of a Novel Kv3 Potassium Channel Modulator.

Authors:  Puja K Parekh; Michelle M Sidor; Andrea Gillman; Darius Becker-Krail; Letizia Bettelini; Roberto Arban; Giuseppe S Alvaro; Erika Zambello; Chiara Mutinelli; Yanhua Huang; Charles H Large; Colleen A McClung
Journal:  Neuropsychopharmacology       Date:  2017-08-31       Impact factor: 7.853

10.  Rapid antidepressant effects: moving right along.

Authors:  K Martinowich; D V Jimenez; C A Zarate; H K Manji
Journal:  Mol Psychiatry       Date:  2013-05-21       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.